Mondelez International
MDLZ
59.38
-0.24
-0.40%
Mondelez International
US · MDLZ
#286 by market cap
Listed 2012
59.38
-0.24
-0.40%
Live - 5344 symbols - heartbeat 127s ago
· 2026-10-08 08:32
Pre-market
59.38
0.00%
After-hours
59.25
-0.22%
Overnight
59.43
+0.08%
- Market cap
- 75.79B
- P/E (TTM)i
- 21.75
- P/Bi
- 2.84
- EPSi
- 1.89
- Div yieldi
- 3.37%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on MDLZ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.27, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.75% YoY
Margins
- Gross margin
- 28.38%
- Operating margin
- 9.39%
- Net margin
- 6.36%
Key ratios & quality
- Enterprise valuei
- 94.87B
- Altman Z-Scorei
- 2.27
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.94B | 25.87B | 26.58B | 28.72B | 31.50B | 36.02B | 36.44B | 38.54B |
| Gross profit | 10.35B | 10.34B | 10.45B | 11.25B | 11.31B | 13.76B | 14.26B | 10.94B |
| Selling & admin expenses | 6.48B | 6.14B | 6.10B | 6.26B | 7.38B | 8.00B | 7.44B | 7.17B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.70B | 4.03B | 4.15B | 4.86B | 3.80B | 5.61B | 6.67B | 3.62B |
| Pretax profit | 2.84B | 3.45B | 3.38B | 4.37B | 3.23B | 5.88B | 6.26B | 3.01B |
| Tax | 773.00M | 2.00M | 1.22B | 1.19B | 865.00M | 1.54B | 1.47B | 782.00M |
| Net profit | 3.33B | 3.94B | 3.57B | 4.31B | 2.73B | 4.97B | 4.62B | 2.47B |
| Basic EPS | 2 | 3 | 2 | 3 | 2 | 4 | 3 | 2 |
| Diluted EPS | 2.23 | 2.69 | 2.47 | 3.04 | 1.96 | 3.62 | 3.42 | 1.89 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 9.31B | 8.98B | 9.74B | 10.50B | 10.08B | 9.36B |
| Gross profit | 2.43B | 2.94B | 2.61B | 2.96B | 2.80B | 3.99B |
| Selling & admin expenses | 1.71B | 1.73B | 1.80B | 1.94B | 1.92B | 2.00B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 682.00M | 1.17B | 785.00M | 979.00M | 860.00M | 1.96B |
| Pretax profit | 545.00M | 855.00M | 695.00M | 919.00M | 775.00M | 1.90B |
| Tax | 154.00M | 230.00M | 137.00M | 261.00M | 228.00M | 364.00M |
| Net profit | 407.00M | 644.00M | 746.00M | 669.00M | 564.00M | 1.55B |
| Basic EPS | 0 | 0 | 1 | 1 | 0 | 1 |
| Diluted EPS | 0.31 | 0.49 | 0.57 | 0.51 | 0.44 | 1.20 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 7.60B | 7.63B | 9.98B | 10.34B | 10.09B | 11.70B | 13.24B | 12.95B |
| Cash & ST investments | 1.10B | 1.29B | 3.62B | 3.55B | 1.92B | 1.81B | 1.35B | 2.13B |
| Inventory | 2.59B | 2.55B | 2.65B | 2.71B | 3.38B | 3.62B | 3.83B | 4.42B |
| Total assets | 62.73B | 64.52B | 67.81B | 67.09B | 71.16B | 71.39B | 68.50B | 71.49B |
| Total current liabilities | 16.74B | 15.32B | 15.16B | 14.01B | 16.73B | 19.01B | 19.55B | 21.86B |
| Short-term debt | 5.84B | 4.22B | 2.77B | 1.96B | 2.68B | 2.52B | 2.09B | 3.98B |
| Long-term debt | 12.53B | 14.12B | 17.09B | 17.39B | 20.25B | 16.89B | 15.66B | 17.22B |
| Total liabilities | 37,016,000,000.00 | 37,198,000,000.00 | 40,156,000,000.00 | 38,769,000,000.00 | 44,241,000,000.00 | 43,025,000,000.00 | 41,539,000,000.00 | 45,596,000,000.00 |
| Total equity | 25.71B | 27.32B | 27.65B | 28.32B | 26.92B | 28.37B | 26.96B | 25.89B |
| Retained earnings | 24.49B | 26.62B | 28.40B | 30.81B | 31.48B | 34.24B | 36.48B | 36.41B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 12.73B | 12.75B | 13.15B | 12.95B | 12.75B | 12.94B |
| Cash & ST investments | 1.56B | 1.50B | 1.37B | 2.13B | 1.52B | 1.72B |
| Inventory | 4.26B | 4.95B | 5.10B | 4.42B | 4.08B | 4.41B |
| Total assets | 68.93B | 71.02B | 71.36B | 71.49B | 71.12B | 71.25B |
| Total current liabilities | 21.00B | 19.88B | 21.51B | 21.86B | 23.50B | 21.59B |
| Short-term debt | 3.74B | 2.77B | 4.19B | 3.98B | 5.56B | 4.99B |
| Long-term debt | 15.80B | 18.12B | 17.13B | 17.22B | 15.47B | 16.46B |
| Total liabilities | 43,104,000,000.00 | 44,773,000,000.00 | 45,129,000,000.00 | 45,596,000,000.00 | 45,318,000,000.00 | 44,555,000,000.00 |
| Total equity | 25.82B | 26.25B | 26.23B | 25.89B | 25.80B | 26.69B |
| Retained earnings | 36.26B | 36.29B | 36.39B | 36.41B | 36.33B | 37.23B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.95B | 3.97B | 3.96B | 4.14B | 3.91B | 4.71B | 4.91B | 4.51B |
| Depreciation & amortization | 811.00M | 1.05B | 1.12B | 1.11B | 1.11B | 1.22B | 1.30B | 1.36B |
| Free cash flow | 2.85B | 3.04B | 3.10B | 3.18B | 3.00B | 3.60B | 3.52B | 3.24B |
| Dividends paid | -1.36B | -1.54B | -1.68B | -1.83B | -1.99B | -2.16B | -2.35B | -2.49B |
| Stock buybacks / issuance | -2.02B | -1.48B | -1.39B | -2.11B | -2.02B | -1.55B | -2.33B | -2.39B |
| Ending cash balance | 1.10B | 1.33B | 3.65B | 3.55B | 1.95B | 1.88B | 1.40B | 2.20B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.09B | 308.00M | 717.00M | 2.40B | 467.00M | 855.00M |
| Depreciation & amortization | 324.00M | 339.00M | 343.00M | 352.00M | 343.00M | 350.00M |
| Free cash flow | 815.00M | 3.00M | 418.00M | 2.00B | 155.00M | 513.00M |
| Dividends paid | -623.00M | -610.00M | -609.00M | -645.00M | -644.00M | -643.00M |
| Stock buybacks / issuance | -1.52B | -131.00M | -240.00M | -492.00M | 0 | -212.00M |
| Ending cash balance | 1.63B | 1.59B | 1.47B | 2.20B | 1.63B | 1.76B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.07 | 14.63 | 12.96 | 15.40 | 9.85 | 17.96 | 16.69 | 9.29 |
| ROA %i | 5.37 | 6.08 | 5.37 | 6.38 | 3.93 | 6.96 | 6.59 | 3.50 |
| ROIC %i | 8.47 | 9.66 | 8.12 | 9.48 | 6.15 | 10.52 | 10.15 | 5.72 |
| 5-year avg ROE %i | 12.68 | 14.20 | 11.58 | 13.43 | 13.19 | 14.21 | 14.57 | 13.84 |
| EBIT margin %i | 12.74 | 15.20 | 14.32 | 16.48 | 11.61 | 17.85 | 18.58 | 9.38 |
| FCF / sales %i | 11.00 | 11.75 | 11.67 | 11.06 | 9.53 | 10.00 | 9.67 | 8.39 |
| Current ratioi | 0.45 | 0.50 | 0.66 | 0.74 | 0.60 | 0.62 | 0.68 | 0.59 |
| Quick ratioi | 0.25 | 0.28 | 0.43 | 0.48 | 0.35 | 0.33 | 0.32 | 0.32 |
| Debt / assetsi | 29.29 | 29.19 | 30.26 | 29.77 | 32.95 | 27.94 | 26.82 | 30.50 |
| LT debt / equityi | 48.88 | 53.63 | 64.35 | 63.71 | 77.24 | 61.50 | 60.47 | 68.97 |
| Interest coveragei | 7.15 | 8.12 | 9.00 | 12.97 | 8.54 | 11.69 | 13.32 | 6.03 |
| Revenue CAGR (3Y) %i | -4.35 | -0.07 | 0.87 | 3.45 | 6.78 | 10.66 | 8.26 | 6.96 |
| Net income CAGR (3Y) %i | -23.00 | 33.94 | 7.92 | 9.04 | -11.57 | 11.73 | 2.36 | -3.38 |
| FCF CAGR (3Y) %i | 8.82 | 23.50 | 25.23 | 3.64 | -0.42 | 5.12 | 3.52 | 2.52 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.27 | 13.51 | 13.07 | 9.29 | 10.13 | 13.31 |
| ROA %i | 4.91 | 5.05 | 4.92 | 3.50 | 3.73 | 4.94 |
| ROIC %i | 8.51 | 8.50 | 8.28 | 5.72 | 6.55 | 7.64 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.74 | 12.59 | 11.33 | 9.38 | 9.81 | 12.33 |
| FCF / sales %i | 9.09 | 7.71 | 6.08 | 8.39 | 6.55 | 7.78 |
| Current ratioi | 0.61 | 0.64 | 0.61 | 0.59 | 0.54 | 0.60 |
| Quick ratioi | 0.32 | 0.31 | 0.31 | 0.32 | 0.29 | 0.31 |
| Debt / assetsi | 29.24 | 30.28 | 30.74 | 30.50 | 30.40 | 30.96 |
| LT debt / equityi | 63.65 | 71.52 | 67.79 | 68.97 | 62.39 | 64.08 |
| Interest coveragei | 8.89 | 8.59 | 7.45 | 6.03 | 6.32 | 8.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Biscuits & Baked Snacks is the largest reported line at 50.61% of revenue, across 5 reported segments.
- Chocolate follows at 29.09%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Biscuits & Baked Snacks50.61%
Chocolate29.09%
Gum & Candy11.41%
Meals6.48%
Beverages2.42%
Quote time 2026-10-08 08:32:48 · For reference only, not investment advice and not tailored to your situation.